Biofilm-disrupting effects of phage endolysins LysAm24, LysAp22, LysECD7, and LysSi3: breakdown the matrix

doi:10.21203/rs.3.rs-3899892/v1

Download PDF

Research Article

Biofilm-disrupting effects of phage endolysins LysAm24, LysAp22, LysECD7, and LysSi3: breakdown the matrix

https://doi.org/10.21203/rs.3.rs-3899892/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 29 Apr, 2024

Read the published version in World Journal of Microbiology and Biotechnology →

You are reading this latest preprint version

The ability of most opportunistic bacteria to form biofilms, coupled with antimicrobial resistance, hinder the efforts to control widespread infections, resulting in high risks of negative outcomes and economic costs. Endolysins are promising compounds that efficiently combat bacteria, including multidrug-resistant strains and biofilms, without the subsequent emergence of endolysin-resistant genotypes. However, the details of antibiofilm effects of these enzymes are poorly understood. To elucidate the interactions of bacteriophage endolysins LysAm24, LysAp22, LysECD7, and LysSi3 with bacterial films formed by Gram-negative species, we estimated their composition and assessed the endolysins’ effects on the most abundant exopolymers in vitro. The obtained data suggests a pronounced efficiency of these lysins against biofilms with high (Klebsiella pneumoniae) and low (Acinetobacter baumannii) matrix contents, or dual-species biofilms, resulting in at least a 2-fold loss of the biomass. These peptidoglycan hydrolases interacted diversely with protective compounds of biofilms such as extracellular DNA and polyanionic carbohydrates, indicating a spectrum of biofilm-disrupting effects for bacteriolytic phage enzymes. Specifically, we detected disruption of acid exopolysaccharides by LysAp22, strong DNA-binding capacity of LysAm24, both of these interactions for LysECD7, and neither of them for LysSi3.

antibiofilm activity

biofilm

endolysin

exopolysaccharides

extracellular DNA

Bacterial biofilm (BF) is a community of immobilized and phenotypically altered microorganisms embedded in self-produced exogenous polymeric substances (EPSs) (Donlan and Costerton 2002; Karygianni et al. 2020). In particular, biofilm-related phenotype is formed by various matrix structures and chemical compositions, such as exopolysaccharides, extracellular DNA (eDNA), proteins, lipids and membrane vesicles, low molecular compounds (for example, “quorum sensing” ligands, cyclic di-GMP, accumulated water, and polyvalent ions). These heterogeneous constituents greatly impact biofilm formation, sustainability, availability of nutrients, and tolerance toward antiseptics, antibiotics and bacteriophages. Being one of the most abundant states of bacterial existence both in natural and human-made environments, BFs have great biological significance owing to efficient expansion of the community and increased survival rates under severe conditions (Donlan and Costerton 2002; Flemming et al. 2016).

Specifically, there are challenges in the therapy of diseases associated with Gram-negative opportunistic bacteria, such as Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli, associated with rapid emergence of multidrug-resistance traits and hardly removable biofilms formed within the host organisms and on surfaces of hospital equipment and prosthetic devices. These features together with advanced natural antibiotic resistance led to a notable increase in the probability of negative outcomes, formation of persistent infection and spread of nosocomial infections (Omar et al. 2017; Stewart 2015). Despite actively developed restrictive measures to control Gram-negative pathogens, there are limited innovative treatment approaches (Giacobbe et al. 2018; Prasad et al. 2022), while common chemotherapy is often considered as non-effective or excessively deleterious (Eriksson et al. 2022). At the same time, the search for reliable antibacterial strategies continues, thus an application of nanoparticles, antibodies, bacteriophages, bacteriophage-derived antimicrobial proteins (also called enzybiotics) and peptides (AMPs) are expected to be highly advanced options as a supplementation to antibiotic therapy or as an alternative treatment strategy (Heselpoth et al. 2021; Koo et al. 2017).

Endolysins are promising peptidoglycan-degrading enzybiotics that are already investigated for clinical relevance due to their pronounced activity and safety (Karau et al., 2023). For decades of research on endolysins, no strict evidence of acquired resistance to these proteins has been reported, that is explained particularly by the high fitness costs of most changes in the peptidoglycan, especially across Gram-negative species (Grishin et al. 2020). Several studies reveal an ability of endolysins not only to eliminate multidrug resistant bacteria, but also to efficiently disrupt their biofilms (Arroyo-Moreno et al. 2022; Gutiérrez et al. 2014; Karau et al. 2023). However, the key mechanisms of endolysin-biofilm interactions are uncovered, and the investigation is mostly limited to the fact of BFs disruption and prevention of their formation. Whilst interactions between endolysins and EPSs and their effects on the enzymes’ activity are poorly described.

Our previous research was focused on recombinant endolysins, muramidases LysAm24, LysAp22, LysSi3 and endopeptidase LysECD7, derived from different bacteriophages infected Gram-negative hosts. Recently, promising safety properties and antibacterial activity of the endolysins against a broad spectrum of Gram-negative representatives were described (Antonova et al. 2019), furthermore, highlighted the substantial disruption of 24-h BFs, affected by these enzymes (Vasina et al. 2021). However, the catalytic mechanism of endolysins, associated with the hydrolysis of CW (cell-wall) peptidoglycan bonds, is not enough to explain their influence on preformed BFs, degrading complex three-dimensional structures of the matrix, down to individual bacterial cells. In the present study we investigated the composition of biofilms formed by polyresistant strains of A. baumannii and K. pneumoniae, revealing interactions between either of the endolysins and the abundant defensive compounds of preformed BFs.

Bacterial strains and culture conditions

Acinetobacter baumannii Ts 50 − 16 and Klebsiella pneumoniae F 104 − 14 clinical isolates (collection of the N.F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation), were implicated in the present study as biofilm-forming Gram-negative pathogens of the ESKAPE group. A. baumannii Ts 50 − 16 was isolated from patient’s sputum, intensive care unit, and K. pneumoniae F 104 − 14 was obtained from patient’s sputum, outpatient hospital. Both strains were stored at − 80°C and cultivated in pre-autoclaved Tryptic Soy Broth (TSB; SIFIN, Berlin, Germany) at 37°C, at 250 rpm overnight before performing further tests.

Recombinant expression and purification of proteins

Recombinant endolysins LysAm24, LysAp22, LysECD7, and LysSi3 were obtained as described previously (Vasina et al., 2021). In brief, proteins modified with polyhistidine-tag (8 His) were recombinantly expressed in Escherichia coli BL21(DE3) pLysS strain using 1mM β-D-1-thiogalactopyranoside induction at 37°C for 3 h. The cells were harvested by centrifugation (6,000×g for 10 min at 4°C) and incubated with 100 µg/mL lysozyme in lysis buffer (20 mM Tris-HCl, 250 mM NaCl, and 0.1 mM EDTA, pH = 8.0), and disrupted by sonication. Soluble proteins were purified on an NGC Discovery™ 10 FPLC system (Bio-Rad, Hercules, CA, U.S.) with a HisTrap FF column (GE Healthcare, Munich, Germany) pre-charged with Ni²⁺ ions. The filtered lysate was mixed with 30 mM imidazole and 1 mM MgCl₂ and loaded on the column pre-equilibrated with binding buffer (20 mM Tris–HCl, 250 mM NaCl, and 30 mM imidazole, pH = 8.0). The fractions were eluted using a linear gradient to 100% elution buffer (20 mM Tris–HCl, 250 mM NaCl, and 500 mM imidazole, pH = 8.0). Resulting protein fractions were dialyzed against 20 mM Tris–HCl buffer (pH = 7.5).

The purity of endolysins was determined by 16% SDS-PAGE, and protein concentrations were measured using a spectrophotometer (Implen NanoPhotometer; Implen, München, Germany) at 280 nm and calculated using the predicted extinction coefficients [0.840, 0.831, 1.460, and 1.029 (mg/mL)⁻¹ cm^− 1 for LysAm24, LysAp22, LysECD7, and LysSi3, respectively]. The isoelectric points of endolysins LysAm24, LysAp22, LysECD7, and LysSi3 were predicted using the internet-source http://isoelectric.org.

Biofilm composition and morphology

Macrocolony assays were conducted on solid culture medium with application of three different staining techniques and without any dyes as an intact control. For the formation of BFs, cells from overnight cultures were harvested by centrifugation (6,000×g, 10 min, RT), resuspended in PBS (pH = 7.4), and diluted to achieve a cell density of approximately 3×10⁶ CFU/mL. To obtain dual-species biofilms, the appropriate bacterial suspensions were mixed in a 1:1 (v/v) ratio. Thereafter, 7 µL of the suspension was inoculated onto solid TSB agar medium on 90 mm Petri dishes and BFs were grown at 37°C for 48 h without agitation. All images of colonies were acquired using HD automatic colony counter Scan 300 and provided software (Interscience, Saint-Nom-la-Bretèche, France).

Alcian blue 8GX 0.3% stain (PanReac AppliChem, Darmstadt, Germany) in a 4% acetic acid aqueous solution (pH = 2.5) was prepared to visualize polysaccharides with abundant carboxyl groups. Five mL of pre-filtered Alcian blue stain were carefully dripped on plates containing macrocolonies and then incubated for 15 min at RT without agitation. Subsequently, the plates were rinsed with 5 mL of deionised distilled water.

The results were confirmed by the Congo red stain absorption test (Freeman et al., 1989). For this, TSB agar was supplemented with pre-filtered 0.08% Congo red stain (Sigma, U.S.) to prepare agar plates. The 48-h old biofilms were cultured on the medium at 37°C without agitation. The intensity of red staining was considered proportional to the quantity of extracellular polysaccharides and proteins (Ahmad et al., 2020).

The morphotyping assay was conducted according to (Römling et al. 1998) with modifications. In brief, TSB agar was supplemented with a CRCB aqueous mixture, made up of pre-filtered 0.04% Congo red stain and 0.02% Coomassie blue G-250 stain (VWR (Avantor), Radnor, U.S.) to prepare agar-containing Petri dishes. Biofilms were grown on these CRCB agar plates for 24, 48, and 144 hours.

Microtiter biofilm formation assay (CV Mtp)

Overnight bacterial cultures in TSB were harvested (6,000×g, 10 min, RT), then suspended in PBS (pH = 7.4), diluted in the buffer to achieve a cell density of approximately 3×10⁶ CFU/mL. Next, 100 µL of the suspension was added to sterile wells of a 96-well polystyrene cell culture plate, and incubated for 48 h at 37°C and 200 rpm. To obtain dual-species biofilms suspensions of both bacteria were mixed in a 1:1 (v/v) ratio. The wells’ content with planktonic cells was discarded, and the plate was washed three times with 200 µL of PBS (pH = 7.4), then air-dried for approximately 20 min. The dried BFs were stained with a 0.1% aqueous solution of Crystal violet (CV) for 15 min, at RT, followed by triple rinsing with water. The stained content was resolubilized in 200 µL of 33% acetic acid, and OD₅₉₀ of the obtained solutions was measured using SPECTROstar NANO spectrophotometer (BMG LABTECH, Ortenberg, Germany). All experiments were performed with quadruplicate technical replicates and repeated at least in two independent assays. The values were normalized by dividing them by the OD₅₉₀ of biofilm treated with the blank buffer. The level of biofilm formation was interpreted according to (Stepanović et al. 2007).

Quantification of eDNA in the biofilm

A measurement of eDNA was carried out with DNAse I (PanReac AppliChem, Darmstadt, Germany) treatment of biofilms, grown for 24 and 48 h. BFs were grown as described in the subsection “Microtiter biofilm formation assay” and treated with 100 µL of DNAse I solution (20 µg/mL of DNAse I in 20 mM Tris-HCl buffer, 1 mM CaCl₂ (pH = 7.5)) or the same volume of the buffer at 37°C and 200 rpm, for 2 h. Thereafter, biofilms were rinsed with water, air-dried, and stained with 0.1% Crystal violet, following the OD₅₉₀ measurement. The eDNA content was calculated as the difference in BF staining with and w/o of DNAse I treatment (BF biomass reduction).

Quantification of proteins content in the biofilm

A measurement of proteins’ quantity was conducted for 24- and 48-h old biofilms. Proteinase K (PanReac Applichem, Darmstadt, Germany) in 20 mM Tris-HCl buffer supplemented with 100 mM NaCl, 1 mM CaCl₂ (pH = 7.5), at 50 and 800 µg/mL concentration was added to A. baumannii biofilms; and at 50, 800 and 1600 µg/mL concentration was added to K. pneumoniae biofilms. Preformed biofilms were treated with 100 µL of Proteinase K solutions or blank buffer at 37°C and 200 rpm, for 2 h. Thereafter, treated biofilms were rinsed, air-dried, stained with Crystal violet and analyzed as described in the subsection “Quantification of eDNA in the biofilm”.

Antibiofilm activity assessment

Mono-species and dual-species biofilms grown for 48 h and prepared for microtiter assay, were treated with either 100 µL of endolysin solutions at concentrations of 100 or 1000 µg/mL, or equal volume of 20 mM Tris-HCl (pH = 7.5) buffer as a negative control, for 2 h at 37°C and 200 rpm. After incubation, biofilms were rinsed twice, air-dried, stained with 0.1% Crystal violet, rinsed again, dissolved and analyzed as was described in the subsection “Microtiter biofilm formation assay”.

Microscopy of biofilms

Sterile glass coverslips (Hampton Research, Aliso Viejo, CA, U.S.) were plunged into the overnight cultures, diluted in fresh TSB medium on Petri dishes and incubated at 37°C for 48 h without shaking. The slides were then carefully washed three times with sterile distilled water and air-dried. Two slides were treated with 300 µL of 20 mM Tris–HCl (pH = 7.5) control buffer, other pairs of slides were exposed to 300 µL of 100 µg/mL LysAm24, LysAp22, LysECD7, or LysSi3 solutions for 2 h at RT. Afterward, all slides were again washed with water two times. Air-dried slides were stained with a 0.1% aqueous solution of Crystal violet for 15 min at RT. All stained samples were rinsed once with water. Then, half of the slides were immediately rinsed twice and air-dried for microscopy. Another half of the slides were negatively stained to identify acid polysaccharides, which are crucial for antibacterial tolerance in most bacterial capsules and biofilms. A negative stain was performed using the Anthony method (Hughes and Smith 2013) with modifications. Following the method, CV-stained slides were submerged into 20% aqueous CuSO₄ for 10 s, rinsed thoroughly with water, and then dried. All slides were imaged using Axiostar Plus Transmitted Light Microscope (Zeiss AG, Jena, Germany) at ×630 magnification.

DNA-binding effect of the endolysins

To detect interaction between eDNA and the endolysins we obtained genomic DNA of A. baumannii using a modified CTAB method (Minas et al. 2011). Briefly, cells from an overnight bacterial culture were harvested, once washed, and solubilized in a CTAB solution (2% w/v cetrimonium bromide (Helicon, Moscow, Russia), 100 mM Tris-HCl, 20 mM EDTA and 1.4 M NaCl, pH = 8.0), ex tempore supplemented with 0.2% β-mercaptoethanol, at 65°C for 40 min. Then, the suspensions were mixed with an equal volume of chloroform-isoamyl alcohol (24:1), and the aqueous phase was collected after centrifugation at 12,000×g for 10 min, RT. The DNA precipitation proceeded in 0.6 volume of isopropanol overnight at – 25°C. The precipitates were harvested at 8,000×g for 15 min and washed three times with 80% ethanol. After ethanol was discarded, the pellets were suspended in 20 mM Tris-HCl (pH = 7.5) buffer with 1 µg/mL RNAse A (PanReac Applichem, Darmstadt, Germany), incubated for 15 min at 37°C, afterwards RNAse A was inactivated at 65°C for 15 min. Quality of the DNA samples was estimated spectrophotometrically, analyzing A260/230 and A260/280, thereafter a concentration of DNA was measured using Qubit DNA HS Assay Kit and Qubit 3.0 fluorometer (Thermo Fisher Scientific Eugene, Oregon, U.S.).

Endolysins LysAm24, LysAp22, LysECD7, and LysSi3 solutions in 20 mM Tris-HCl buffer at 10 or 50 ng/µL concentration were mixed with DNA solutions (at a concentration of 20 ng/µL) at a protein:DNA (P:DNA) mass ratio of 2:1 or 10:1 (final volume of the mixtures was 7.5 µL) and incubated for 30 min at RT. Solutions containing either DNA or investigated endolysin in 20 mM Tris-HCl buffer (pH = 7.5) were used as control. The influence of electrostatic interactions was assessed by adding NaCl to final concentrations of 150 or 300 mM to the mixtures (P:DNA w/w ratio of 10:1) during their incubation. Post-incubated solutions were mixed with the 6X DNA Loading Dye (Thermo Fisher Scientific Eugene, Oregon, U.S.) and loaded in 1% agarose gel, containing 0.2 µg/mL ethidium bromide (Helicon, Moscow, Russia). An electrophoretic separation of all samples was performed in the Tris-borate buffer (50 mM Tris-base, 50 mM boric acid, 2 mM EDTA, pH = 8.3) at 80 V for an hour. Imaging was performed using the Gel Doc EZ gel documentation system (Bio-Rad, Hercules, CA, U.S.).

To correlate the binding assay with the inhibitory effect of eDNA, an antibacterial activity test was performed. An overnight bacterial culture of A. baumannii was diluted 30-fold in LB broth and grown to the exponential phase (OD₆₀₀ = 0.6). Subsequently, the cells were harvested by centrifugation (6,000×g, 10 min) and resuspended in the same volume of PBS (pH = 7.4). Each suspension was diluted in the 20 mM Tris-HCl (pH = 7.5) to a final density of approximately 10⁶ cells/mL. Afterward, 100 µL of the bacterial suspensions and 100 µL of the pre-incubated protein-DNA solutions (a final protein concentration was 10 µg/mL, a final DNA concentration was 1 or 5 µg/mL) were mixed in 96-well plates. Buffers with or without DNA were used as the negative controls. The mixtures were incubated at 37°C for 30 min with shaking at 200 rpm and then were diluted 10-fold in PBS (pH = 7.4). Then, 100 µl of each dilution were plated onto LB agar, and the number of bacterial colonies were counted after an overnight incubation at 37°C. All experiments were performed in quadruplicate, and the antibacterial activity was expressed as follows: Antibacterial activity (%) = 100% – (CFUexp/CFUcont) × 100%, where CFUexp is the number of bacterial colonies in the experimental culture plates, and CFUcont is the mean number of bacterial colonies in the control culture plates.

Statistical Analysis

The data were analyzed and illustrated using GraphPad Prism 9.0 software. According to the results of normality tests (Kolmogorov-Smirnov’s method), data sets were compared using appropriate statistical tests with corrections for multiple comparisons (detailed information on the chosen analysis methods is provided in captions and results).

Exopolysaccharides content

To visualize different EPSs, various staining procedures of bacterial BF-macrocolonies on nutritious media with glucose are often implemented. Cultivation of bacterial macrocolonies on solid medium, containing Congo red (CR) dye is an express test system of biofilm formation properties. CR interacts with most β-folded proteins, glucans with β (1->4) and β (1->3) bonds, and with various polycationic polysaccharides (Puchtler et al. 1962). During the 48-h incubation on CR agar, the investigated bacterial colonies accumulated small amounts of the stain and slightly decolorized the medium (Fig. 1a, the second row). The K. pneumoniae originated macrocolonies with a crystalline red center and sharp, clear edges, while A. baumannii formed homogeneous brown and rough colonies indicating production of moderate quantity of polysaccharides and amyloid proteins. Dual-species colonies resembled those of K. pneumoniae, with a rougher structure and partially colored periphery.

A different matrix architecture was observed by staining with polycationic dye Alcian blue, revealing carboxyl-rich polysaccharides (Scott and Dorling 1965), located on the air-contacting exterior of formed macrocolonies (Fig. 1a, the third row). The colonies of K. pneumoniae had a concentric staining, significantly more intense compared to A. baumannii, while the dual-species colonies possessed well resolved dark-blue strands radiating from the center, revealing the conglomerated polycationic and polyanionic polysaccharides’ plots.

To investigate the coexistence of bacteria in mixed biofilms the morphotyping assay with culture media containing Coomassie brilliant blue dye (CBB) was done. CBB stains biofilm-associated proteins, and Congo red dye, binding with both proteins and polysaccharides (Nesse et al. 2020). The significant heterogeneity of biofilm composition was observed for dual-species colonies (Fig. 1b and Online Resource Fig. 1) combining phenotypic traits of both species and characterized by increased cell motility.

Quantification of eDNA

The biomass density of either K. pneumoniae or A. baumannii 24-h old biofilms pretreated with DNAse I, was reduced by 20% on average (Fig. 2), while the enzymatic treatment of 48-h biofilms led to a decline in the biofilm biomass by 30.9% and 25.9% respectively. Neither the increase in DNAse I concentration (up to tenfold) nor the time of biofilm formation led to a significant reduction in the BFs’ biomass (p > 0.05, two-way ANOVA with Tukey’s correction).

Quantification of proteins within biofilms

The presence of fibrillar proteins, pili or pilus-like structures within examined biofilms of 24- and 48-h macrocolonies of A. baumannii (brown staining) and K. pneumoniae (red staining) was demonstrated in CRCB-TSB assay (Fig. 1. b). To quantify the approximate content of proteins within the matrix of biofilms, treatment with Proteinase K (PK) was used. It was shown that biofilms of investigated strains, particularly of A. baumannii, were significantly resistant to proteolysis (Fig. 3). No effective concentration of PK was found to disrupt biofilms of A. baumannii, where the addition of 800 µg/mL of PK resulted in a negligible loss of biomass (Fig. 3a). Thereby, proteins make up relatively small fraction of the A. baumannii biofilm matrix (less than 10–15%), although some EPS proteins might evade a proteolysis, for instance, due to aggregation in fibers, O-glycosylation, or their covering by other compounds of the matrix (Iwashkiw et al. 2012).

Twenty-four hours old biofilms formed by K. pneumoniae also remained recalcitrant to the activity of PK (Fig. 3b), that apparently correlated with the results of morphotyping, where 24-h old macrocolonies of K. pneumoniae had no amyloid content (Fig. 1b, the first row). On the contrary, biofilms of K. pneumoniae, grown for 48 hours, were susceptible to the action of Proteinase K, in a dose-dependent manner in concentrations range 50 to 1600 µg/mL of PK, resulting in the loss up to 45% of biomass at 1600 µg/mL. Notably, simultaneous treatment with DNAse and PK did not lead to a synergistic decline in biomass of the investigated biofilms (Online Resource Fig. 2), which indicates tough stability of these BFs, provided by multiple contacts between various EPSs.

Activity of the endolysins against 48-h biofilms

A pronounced reduction in biomass of 48-h old BFs was observed after 2-h incubation with endolysins as shown by the CV Mtp assay for A. baumannii (Fig. 4a), K. pneumoniae (Fig. 4b) or mixed biofilms (Fig. 4c), which all formed moderate or strong BFs on the polystyrene. Depending on the biofilm-forming bacteria, endolysins acted mostly in a dose-dependent manner. Each protein led to at least a 2-fold loss in the biomass of preformed biofilms, in particular, LysAp22 possessed the strongest disruption of BFs, whilst antibiofilm activity on EPS-rich biofilms by LysSi3 was less evident than that of other endolysins.

Exposure to a 1000 µg/mL of LysAp22 solution decreased the biofilms’ biomass up to 33%, 25% and 27% on average; thus K. pneumoniae-related BFs were almost eliminated (Fig. 4b). Two endolysins, LysECD7 and LysAm24, acted similarly versus mono-species BFs, albeit the impact of LysECD7 on dual-species BFs was comparable to that of LysAp22. The 2-h treatment with LysAm24 or LysECD7 at a concentration of 1000 µg/mL led to a decrease up to approximately 41%, 35% and 27% of A. baumannii, K. pneumoniae or mixed biofilms’ biomass respectively, compared to the controls treated with the buffer. At 100 µg/mL, these proteins exhibited a lower activity. Except for LysSi3, endolysins at a higher concentration removed dual-species biofilms better than low-EPS containing A. baumannii BFs (p < 0.01, Mann-Whitney tests with Holm-Šídák’s correction). LysSi3 acted on mixed biofilms worse than other endolysins, disrupting the biomass by approximately 54%, independently on dose.

Exopolysaccharides and biomass staining of biofilms pretreated with endolysins

As demonstrated, three-dimensional biofilms were formed after a 48-h incubation of A. baumannii cells in TSB media on glass slides (Fig. 5). These aggregates consisted of dense and tightly connected structures (Fig. 5a), which were disrupted by endolysins to incoherent monolayers (BFs treated with LysAm24, LysAp22, LysSi3), or microcolonies (LysECD7). After destaining with CuSO₄, light-blue color of the biofilm’s structures indicated the presence of acid, mostly capsular carbohydrates. Otherwise, if there is a lack of these EPSs, the biomass was colored violet. Thus, it allows to distinguish a significant number of cells covered with capsular polysaccharides and also the heterogeneous arrangement of different EPSs, especially on the BF edges (Fig. 5a’). Biofilms treated with LysAp22 or LysECD7 were poorly stained by CV (Fig. 5c and d), except for a few areas with dark violet peaks, and did not differ from the cells, additionally rinsed with CuSO₄, suggesting interactions with carbohydrates, subsequent dissociation, and destabilization of biofilms’ matrix. The BF-disrupting effect of LysSi3 (Fig. 5e and e’) appeared to be similar to that of LysECD7, however, it was less pronounced, and did not cause evident destabilization of exopolysaccharides, but also efficiently passed through EPSs. A different manner of endolysin-biofilm interactions was observed for LysAm24 (Fig. 5b and b’). Preparations treated with this endolysin and stained with CV possessed an intense violet color, whereas double-stained biofilms apparently lacked any purple areas that demonstrate the interactions between LysAm24 and EPS, other than acid carbohydrates, providing additional sites for CV staining.

Effects of bacterial DNA on endolysins

We estimated that in abundance of endolysins (10:1 ratio), the DNA samples incubated with three out of 4 investigated endolysins displayed a notable decline in the electrophoretic mobility of nucleic acids (Fig. 6a), suggesting the complexes’ formation of endolysin with genomic DNA, which remained in the loading well or formed significant smears. Among the examined proteins, LysAm24 and LysECD7 exhibited the most pronounced DNA-binding activity (Fig. 6a). However, with the exception of LysAm24, endolysin-eDNA complexes were not detected when the ratio of P:DNA was 2:1. Only LysSi3 showed no interactions with DNA samples in this test.

Exogenous nucleic acids led to the inhibition of muramidases’ activity versus free-living A. baumannii cells. At the lower concentration (10:1 ratio), DNA did not impact antibacterial properties of these proteins, whereas it dramatically inhibited them at the ratio of 2:1 (Fig. 6b). At the same time, endopeptidase LysECD7 remained effective against the bacteria even in the excess of DNA.

Clinically relevant biofilms, formed by A. baumannii and K. pneumoniae species or their combination, are associated with a variety of skin and soft tissue infections, as well as nosocomial infections of the respiratory (Said et al. 2022) and urinary tract (Paczosa and Mecsas 2016). Because of producing a heterogeneous and thick matrix, these causative agents possess an extreme tolerance towards various antimicrobials (Stewart 2015). Herein, we characterized the content of biofilms formed by two bacterial isolates and estimated that 48-h A. baumannii BFs contained a moderate amount of highly deacetylated glycosaminoglycans, acid polysaccharides, eDNA, and a relatively large fraction of the cellular biomass (Online Resource Table 1). For K. pneumoniae, the BF matrix makes up at least half of the dry biofilm’s volume, with a pronounced content of negatively charged polysaccharides, DNA, and non-amyloid proteins. Despite the difference in composition, we have shown that investigated enzymes disrupt heterogeneous biofilms, interacting directly with different BF compounds. All of the endolysins at a concentration of 100 µg/mL led to a decrease in biomass of mono- and dual-species films of Gram-negative bacteria by at least 2–3 times. Moreover, treatment with LysAm24, LysAp22, or LysECD7 at a concentration of 1000 µg/mL was linked to the almost complete removal of the biofilms.

Although most endolysins are considered highly specific hydrolases, disrupting the peptidoglycan at specific sites, a side ability to influence compounds of the biofilm matrix could be recognized. Thus, we detected weak interactions between endolysins and exopolysaccharides and eDNA. These interactions, however, were associated with a significant destabilization of the treated biofilm and could be beneficial in terms of bacteriophage ecology. Endolysin-EPS interactions may include effects on adhesion of competitive viruses, availability of phages’ receptors, and formation of cell-wall deficient cells to sustain the host population (Wohlfarth et al. 2023). Furthermore, lysins can be engaged in BF-specific signaling pathways due to the products of peptidoglycan hydrolysis (Irazoki et al. 2019). Extracellular carbohydrates are a significant component involved in biofilm formation, crucial for stable cell adhesion on various surfaces, and establish multiple contacts with other exogenous molecules (Ostapska et al. 2018). They include enterobacterial cellulose (Nesse et al. 2020), and poly-β-1,6-N-acetyl-D-glucosamine (PNAG), found in numerous species of bacteria (Choi et al. 2009). Capsular polysaccharides, frequently consisting of various negatively and neutrally charged subunits, serve as a physical shield against environmental factors (Paczosa and Mecsas 2016; Singh et al. 2019), and within BFs modulate surface adhesion (Mann and Wozniak 2012; Pompilio et al. 2021). Therefore, massive detachment of acid exopolysaccharides by LysAp22 and LysECD7 may impair BF stability, without relevant loss of the antibacterial activity, and subsequently seems to be an intriguing feature for further development of enzybiotics. The exact mechanism of this change is not fully understood. However, it is unlikely to be related to capsule digestion by specific phage depolymerases. In particular, their active sites differ from those of endolysins and structures of the investigated lysins possess no significant similarity with any of this wide group of enzymes. It is worth noting, that exopolysaccharides can trigger changes in the catalytic activity of other enzymes, more related to endolysins. For instance, a polyanionic exopolysaccharide of Xantamonas spp. inhibits egg white lysozyme and lysostaphin, but activates two bacterial muramidases (Stepnaya et al. 2001).

The results of the eDNA-endolysin binding assay partly correlated with the isoelectric points (pIs) of the lysins: LysAp22 (pI 9.19), LysAm24 (pI 8.89), LysECD7 (pI 8.83) and LysSi3 (pI 8.52), proposing a higher probability of binding with an increase of pI. Hence, unspecified electrostatic forces may determine the interactions between the endolysins and eDNA. However, the differences in pIs between the studied proteins are small; thereby an actual net charge distribution of molecules may be distinct, affecting the binding capacity. Anyway, as shown in Online Resource Fig. 3, the strength of the endolysin-DNA association was significantly reduced by the addition of NaCl. Thus, LysECD7 partially ceased to bind with DNA in the mixtures, containing 150 and 300 mM NaCl, LysAm24 showed a similar tendency at the lower salt’s concentration, whereas the DNA-binding effect of LysAp22 was evident in the mixture without NaCl. Therefore, the interplay observed between eDNA and the investigated enzymes should be considered nonspecific, and primarily driven by electrostatic binding. Strong electrostatic interactions are suggested to destabilize eDNA in the cases of LysECD7 and possibly LysAm24, serving as a mechanism for the antibiofilm effect of these enzymes within BF areas depleted in free cations, formed by eDNA. LysSi3 is believed to have a reduced antibiofilm activity due to the indirect influence of exogenous nucleic acids, while eDNA affected LysAp22 ambivalently. We suggest that DNA mixed with a bacterial suspension can bind positively charged compounds on the outer membrane (OM) of bacteria and enhance their surface hydrophobicity (Das et al. 2014), impairing CW accessibility for either of hydrolases. It is interesting to note, that the investigated endolysins contain positively charged terminal structures putatively involved in permeabilization of membranes, except for LysECD7. The mechanism of passing through OM for LysECD7 is probably based on other, not only electrostatic interactions with a cell’s surface (Antonova et al. 2019).

There is plenty of findings noted extracellular DNA can be a component of biofilm tolerance exhibited by different species against charged antimicrobial peptides (Batoni et al. 2016) and proteins, as well as aminoglycosides (Chiang et al. 2013), fluoroquinolones (Tetz et al. 2009), and non-phage derived lysozymes. In this regard, eDNA interaction with positively charged structures often found in endolysins’ molecules may also affect their catalytic activity and access to target sites, hampering endolysin-based therapy. On the other hand, enzybiotics may destabilize exposed biofilms through unspecific interactions with extracellular nucleic acids, allowing biofilm control. For example, side antibacterial effects have been reported for egg lysozyme and antistaphylococcal chimeric peptidoglycan hydrolase (Fernández et al. 2017; Liu et al. 2023). It has been proposed to be based on strong endolysin-DNA binding, that influence the expression of bacterial genes. Another interesting mechanism of biofilm removal by targeting defensive BF compounds has been reviewed for a few AMPs, which possess similarity with semi-conservative structures of the studied proteins (Batoni et al. 2016).

Therefore, our study reveals contrasting aspects in the antibiofilm activity of the phage endolysins, which deviated from bacterial cell lysis caused by catalytic digestion of the CW peptidoglycan. Specifically, we detected the interaction with the carbohydrate component of the matrix (LysAp22 and LysECD7), as well as the electrostatic binding of polycationic sites of endolysins to eDNA (LysAm24 and LysECD7). These interactions result in the biofilm removal by endolysins, despite a decrease in their initial antibacterial activity. However, this research did not evaluate the influence of abnormal lysin-induced release of various bacterial compounds on the stability of BFs, which could also be compelling. Additional experiments should be conducted to clarify the endolysin-exoproteome interactions (De Gregorio et al. 2015), whilst details in endolysin-exopolysaccharides association could be investigated through a mass-spectrometric structural analysis accompanied by a design of possible binding in silico. Treatment of biofilms with the cell-free lysate or products of the peptidoglycan hydrolysis could also provide additional information. Thus, the present and further findings are expected to highlight a complex mechanism underlying the endolysins’ antibiofilm activity, allowing them to successfully evade a biofilm’s defense, provided by its matrix.

Ethics approval and consent to participate: Not applicable

Consent for publication: Not applicable

Availability of data and materials: The data that support the findings of this study are available within the paper and its Supplementary Information. Additionally, the raw data are available from the authors upon reasonable request.

Competing interests: The authors have no financial or proprietary interests in any material discussed in this article.

Fundings: The study was supported by the Russian Science Foundation (RSF), grant № 23-74-10027, https://rscf.ru/project/23-74-10027/.

Authors’ contributions: Conceptualization: Daria V. Vasina; Methodology: Anastasiya M. Lendel; Formal analysis and investigation: Anastasiya M. Lendel, Nataliia P. Antonova, Igor V. Grigoriev, Evgeny V. Usachev; Writing - original draft preparation: Anastasiya M. Lendel; Writing - review and editing: Nataliia P. Antonova, Igor V. Grigoriev, Daria V. Vasina; Funding acquisition: Daria V. Vasina; Resources and project administration: Vladimir A. Gushchin; Supervision: Daria V. Vasina. All authors have read and approved the manuscript.

Acknowledgements: Not applicable

Authors' information: Not applicable

Ahmad, I., Nygren, E., Khalid, F., Myint, S.L., Uhlin, B.E., 2020. A Cyclic-di-GMP signaling network regulates biofilm formation and surface associated motility of Acinetobacter baumannii 17978. Sci. Rep. 10, 1–11. https://doi.org/10.1038/s41598-020-58522-5
Antonova, N.P., Vasina, D.V., Lendel, A.M., Usachev, E.V., Makarov, V.V., Gintsburg, A.L., Tkachuk, A.P., Gushchin, V.A., 2019. Broad Bactericidal Activity of the Myoviridae Bacteriophage Lysins LysAm24, LysECD7, and LysSi3 against Gram-Negative ESKAPE Pathogens. Viruses 11, 284. https://doi.org/10.3390/v11030284
Arroyo-Moreno, S., Cummings, M., Corcoran, D.B., Coffey, A., McCarthy, R.R., 2022. Identification and characterization of novel endolysins targeting Gardnerella vaginalis biofilms to treat bacterial vaginosis. npj Biofilms Microbiomes 8, 29. https://doi.org/10.1038/s41522-022-00285-0
Batoni, G., Maisetta, G., Esin, S., 2016. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim. Biophys. Acta, Biomembr. 1858, 1044–1060. https://doi.org/10.1016/j.bbamem.2015.10.013
Chiang, W.C., Nilsson, M., Jensen, P.Ø., Høiby, N., Nielsen, T.E., Givskov, M., Tolker-Nielsen, T., 2013. Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa Biofilms. Antimicrob. Agents Chemother. 57, 2352–2361. https://doi.org/10.1128/AAC.00001-13
Choi, A.H.K., Slamti, L., Avci, F.Y., Pier, G.B., Maira-Litrán, T., 2009. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-β-1-6-N-acetylglucosamine, which is critical for biofilm formation. J. Bacteriol. 191, 5953–5963. https://doi.org/10.1128/JB.00647-09
Das, T., Sehar, S., Koop, L., Wong, Y.K., Ahmed, S., Siddiqui, K.S., Manefield, M., 2014. Influence of calcium in extracellular DNA mediated bacterial aggregation and biofilm formation. PloS One 9, e91935. https://doi.org/10.1371/journal.pone.0091935
De Gregorio, E., Del Franco, M., Martinucci, M., Roscetto, E., Zarrilli, R., Di Nocera, P.P., 2015. Biofilm-associated proteins: News from Acinetobacter. BMC Genomics 16, 1–14. https://doi.org/10.1186/s12864-015-2136-6
Donlan, R.M., Costerton, J.W., 2002. Biofilms: Microbial life on surfaces. Emerg. Infect. Dis. 8, 881–890. https://doi.org/10.3201/eid0809.020063
Eriksson, E., Liu, P.Y., Schultz, G.S., Martins‐Green, M.M., Tanaka, R., Weir, D., Gould, L.J., Armstrong, D.G., Gibbons, G.W., Wolcott, R., 2022. Chronic wounds: Treatment consensus. Wound Rep. Reg. 30, 156–171. https://doi.org/10.1111/wrr.12994
Fernández, L., González, S., Campelo, A.B., Martínez, B., Rodríguez, A., García, P., 2017. Downregulation of Autolysin-Encoding Genes by Phage-Derived Lytic Proteins Inhibits Biofilm Formation in Staphylococcus aureus. Antimicrob. Agents Chemother. 61, e02724-16. https://doi.org/10.1128/AAC.02724-16
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S.A., Kjelleberg, S., 2016. Biofilms: an emergent form of bacterial life. Nat. Rev. Microbiol. 14, 563–575. https://doi.org/10.1038/nrmicro.2016.94
Freeman, D.J., Falkiner, F.R., Keane, C.T., 1989. New method for detecting slime production by coagulase negative staphylococci. J. Clin. Pathol. 42, 872–874. https://doi.org/10.1136/jcp.42.8.872
Giacobbe, D.R., Mikulska, M., Viscoli, C., 2018. Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria. Expert Rev. Clin. Pharmacol. 11, 1219–1236. https://doi.org/10.1080/17512433.2018.1549487
Grishin, A.V., Karyagina, A.S., Vasina, D.V., Vasina, I.V., Gushchin, V.A., Lunin, V.G., 2020. Resistance to peptidoglycan-degrading enzymes. Crit. Rev. Microbiol. 46, 703–726. https://doi.org/10.1080/1040841X.2020.1825333
Gutiérrez, D., Ruas-Madiedo, P., Martínez, B., Rodríguez, A., García, P., 2014. Effective removal of staphylococcal biofilms by the endolysin LysH5. PLoS ONE 9, e107307. https://doi.org/10.1371/journal.pone.0107307
Heselpoth, R.D., Swift, S.M., Linden, S.B., Mitchell, M.S., Nelson, D.C., 2021. Enzybiotics: Endolysins and Bacteriocins, in: Harper, D.R., Abedon, S.T., Burrowes, B.H., McConville, M.L. (Eds.), Bacteriophages: Biology, Technology, Therapy. Springer International Publishing, Cham, pp. 989–1030. https://doi.org/10.1007/978-3-319-41986-2_34
Hughes, R. B., Smith, A.C., 2013. Capsule Stain Protocols. Am. J. Microbiol. 13, 1–12.
Irazoki, O., Hernandez, S.B., Cava, F., 2019. Peptidoglycan Muropeptides: Release, Perception, and Functions as Signaling Molecules. Front. Microbiol. 10, 500. https://doi.org/10.3389/fmicb.2019.00500
Iwashkiw, J.A., Seper, A., Weber, B.S., Scott, N.E., Vinogradov, E., Stratilo, C., Reiz, B., Cordwell, S.J., Whittal, R., Schild, S., Feldman, M.F., 2012. Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. PLoS Pathog. 8, e1002758. https://doi.org/10.1371/journal.ppat.1002758
Karau, M.J., Mandrekar, J., Lehoux, D., Schuch, R., Cassino, C., Patel, R., 2023. In vitro activity of exebacase against methicillin-resistant Staphylococcus aureus biofilms on orthopedic Kirschner wires. BMC Res. Notes 16, 209. https://doi.org/10.1186/s13104-023-06468-y
Karygianni, L., Ren, Z., Koo, H., Thurnheer, T., 2020. Biofilm Matrixome: Extracellular Components in Structured Microbial Communities. Trends Microbiol. 28, 668–681. https://doi.org/10.1016/j.tim.2020.03.016
Koo, H., Allan, R.N., Howlin, R.P., Stoodley, P., Hall-Stoodley, L., 2017. Targeting microbial biofilms: Current and prospective therapeutic strategies. Nat. Rev. Microbiol. 15, 740–755. https://doi.org/10.1038/nrmicro.2017.99
Liu, L., Jia, X., Zhao, X., Li, T., Luo, Z., Deng, R., Peng, B., Mao, D., Liu, H., Zheng, Q., 2023. In vitro PCR verification that lysozyme inhibits nucleic acid replication and transcription. Sci. Rep. 13, 6383. https://doi.org/10.1038/s41598-023-33228-6
Mann, E.E., Wozniak, D.J., 2012. Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol. Rev. 36, 893–916. https://doi.org/10.1111/j.1574-6976.2011.00322.x
Minas, K., McEwan, N.R., Newbold, C.J., Scott, K.P., 2011. Optimization of a high-throughput CTAB-based protocol for the extraction of qPCR-grade DNA from rumen fluid, plant and bacterial pure cultures. FEMS Microbiol. Lett. 325, 162–169. https://doi.org/10.1111/j.1574-6968.2011.02424.x
Nesse, L.L., Osland, A.M., Mo, S.S., Sekse, C., Slettemeås, J.S., Bruvoll, A.E.E., Urdahl, A.M., Vestby, L.K., 2020. Biofilm forming properties of quinolone resistant Escherichia coli from the broiler production chain and their dynamics in mixed biofilms. BMC Microbiol. 20, 46. https://doi.org/10.1186/s12866-020-01730-w
Omar, A., Wright, J.B., Schultz, G., Burrell, R., Nadworny, P., 2017. Microbial biofilms and chronic wounds. Microorganisms 5, 1–15. https://doi.org/10.3390/microorganisms5010009
Ostapska, H., Howell, P.L., Sheppard, D.C., 2018. Deacetylated microbial biofilm exopolysaccharides: It pays to be positive. PLoS Pathog. 14, e1007411. https://doi.org/10.1371/journal.ppat.1007411
Paczosa, M.K., Mecsas, J., 2016. Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Microbiol. Mol. Biol. Rev. 80, 629–661. https://doi.org/10.1128/mmbr.00078-15
Pompilio, A., Scribano, D., Sarshar, M., Di Bonaventura, G., Palamara, A.T., Ambrosi, C., 2021. Gram-Negative Bacteria Holding Together in a Biofilm: The Acinetobacter baumannii Way. Microorganisms 9, 1353. https://doi.org/10.3390/microorganisms9071353
Prasad, N.K., Seiple, I.B., Cirz, R.T., Rosenberg, O.S., 2022. Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020. Antimicrob. Agents Chemother. 66, e00054-22. https://doi.org/10.1128/aac.00054-22
Puchtler, H., Sweat, F., Levine, M., 1962. On the binding of Congo red by amyloid. Journal of Histochemistry & Cytochemistry. 10, 355–364. https://doi.org/10.1177/10.3.355
Römling, U., Sierralta, W.D., Eriksson, K., Normark, S., 1998. Multicellular and aggregative behaviour of Salmonella typhimurium strains is controlled by mutations in the agfD promoter. Mol. Microbiol. 28, 249–264. https://doi.org/10.1046/j.1365-2958.1998.00791.x
Said, K.B., Alsolami, A., Alshammari, F., Alreshidi, F.S., Fathuldeen, A., Alrashid, F., Bashir, A.I., Osman, S., Aboras, R., Alshammari, A., Alshammari, T., Alharbi, S.F., 2022. Selective COVID-19 Coinfections in Diabetic Patients with Concomitant Cardiovascular Comorbidities Are Associated with Increased Mortality. Pathogens 11. 508. https://doi.org/10.3390/pathogens11050508
Scott, J.E., Dorling, J., 1965. Differential staining of acid glycosaminoglycans (mucopolysaccharides) by Alcian blue in salt solutions. Histochemie 5, 221–233. https://doi.org/10.1007/BF00306130
Singh, J.K., Adams, F.G., Brown, M.H., 2019. Diversity and Function of Capsular Polysaccharide in Acinetobacter baumannii. Front. Microbiol. 9, 3301. https://doi.org/10.3389/fmicb.2018.03301
Stepanović, S., Vuković, D., Hola, V., Di Bonaventura, G., Djukić, S., Ćirković, I., Ruzicka, F., 2007. Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115, 891–899. https://doi.org/10.1111/j.1600-0463.2007.apm_630.x
Stepnaya, O.A., Ryazanova, L.P., Krupyanko, V.I., Kulaev, I.S., 2001. Influence of Acidic Exopolysaccharide of Xanthomonas campestris IBPM 124 on the Kinetic Parameters of Extracellular Bacteriolytic Enzymes. Biochemistry (Moscow) 66, 662–666. https://doi.org/10.1023/A:1010263432155
Stewart, P.S., 2015. Antimicrobial Tolerance in Biofilms. Microbiol. Spectr. 3, 269–285. https://doi.org/10.1128/microbiolspec.mb-0010-2014
Tetz, G.V., Artemenko, N.K., Tetz, V.V., 2009. Effect of DNase and antibiotics on biofilm characteristics. Antimicrob. Agents Chemother. 53, 1204–1209. https://doi.org/10.1128/AAC.00471-08
Vasina, D.V., Antonova, N.P., Grigoriev, I.V., Yakimakha, V.S., Lendel, A.M., Nikiforova, M.A., Pochtovyi, A.A., Remizov, T.A., Usachev, E.V., Shevlyagina, N.V., Zhukhovitsky, V.G., Fursov, M.V., Potapov, V.D., Vorobev, A.M., Aleshkin, A.V., Laishevtsev, A.I., Makarov, V.V., Yudin, S.M., Tkachuk, A.P., Gushchin, V.A., 2021. Discovering the Potentials of Four Phage Endolysins to Combat Gram-Negative Infections. Front. Microbiol. 12, 748718. https://doi.org/10.3389/fmicb.2021.748718
Wohlfarth, J.C., Feldmüller, M., Schneller, A., Kilcher, S., Burkolter, M., Meile, S., Pilhofer, M., Schuppler, M., Loessner, M.J., 2023. L-form conversion in Gram-positive bacteria enables escape from phage infection. Nat. Microbiol. 8, 387–399. https://doi.org/10.1038/s41564-022-01317-3

No competing interests reported.

Supplementary26.01.24.docx
Graphicalabstract.jpg
Graphical Abstract

Download PDF

Journal Publication

published 29 Apr, 2024

Read the published version in World Journal of Microbiology and Biotechnology →

Editorial decision: Revision requested
14 Mar, 2024
Reviews received at journal
14 Mar, 2024
Reviews received at journal
22 Feb, 2024
Reviewers agreed at journal
09 Feb, 2024
Reviewers invited by journal
01 Feb, 2024
Editor assigned by journal
31 Jan, 2024
Submission checks completed at journal
31 Jan, 2024
First submitted to journal
26 Jan, 2024

You are reading this latest preprint version

Biofilm-disrupting effects of phage endolysins LysAm24, LysAp22, LysECD7, and LysSi3: breakdown the matrix

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Materials and methods

Bacterial strains and culture conditions

Recombinant expression and purification of proteins

Biofilm composition and morphology

Microtiter biofilm formation assay (CV Mtp)

Quantification of eDNA in the biofilm

Quantification of proteins content in the biofilm

Antibiofilm activity assessment

Microscopy of biofilms

DNA-binding effect of the endolysins

Statistical Analysis

Results

Exopolysaccharides content

Quantification of eDNA

Quantification of proteins within biofilms

Activity of the endolysins against 48-h biofilms

Exopolysaccharides and biomass staining of biofilms pretreated with endolysins

Effects of bacterial DNA on endolysins

Discussion

Declarations

References

Additional Declarations

Supplementary Files

Status:

Journal Publication

Version 1